GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:2000649
|
BP
|
regulation of sodium ion transmembrane transporter activity
|
Any process that modulates the frequency, rate or extent of sodium ion transmembrane transporter activity.
|
FXYD1,
FXYD4,
FGF12,
YWHAH,
RANGRF
|
GO:2000650
|
BP
|
negative regulation of sodium ion transmembrane transporter activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transporter activity.
|
CAMK2D,
PCSK9,
OSR1,
NEDD4L
|
GO:2000651
|
BP
|
positive regulation of sodium ion transmembrane transporter activity
|
Any process that activates or increases the frequency, rate or extent of sodium ion transmembrane transporter activity.
|
DMD,
GLRX,
ANK3,
WNK3
|
GO:2000653
|
BP
|
regulation of genetic imprinting
|
Any process that modulates the frequency, rate or extent of genetic imprinting.
|
PIK3CA,
TRIM28
|
GO:2000657
|
BP
|
negative regulation of apolipoprotein binding
|
Any process that stops, prevents or reduces the frequency, rate or extent of apolipoprotein binding.
|
MAPK3
|
GO:2000660
|
BP
|
negative regulation of interleukin-1-mediated signaling pathway
|
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-1-mediated signaling pathway.
|
IL6,
IL1RN,
IL1R2,
ZNF675
|
GO:2000661
|
BP
|
positive regulation of interleukin-1-mediated signaling pathway
|
Any process that activates or increases the frequency, rate or extent of interleukin-1-mediated signaling pathway.
|
IL1R1
|
GO:2000663
|
BP
|
negative regulation of interleukin-5 secretion
|
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-5 secretion.
|
TNFRSF21
|
GO:2000664
|
BP
|
positive regulation of interleukin-5 secretion
|
Any process that activates or increases the frequency, rate or extent of interleukin-5 secretion.
|
IL17RB
|
GO:2000666
|
BP
|
negative regulation of interleukin-13 secretion
|
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-13 secretion.
|
TNFRSF21
|
GO:2000667
|
BP
|
positive regulation of interleukin-13 secretion
|
Any process that activates or increases the frequency, rate or extent of interleukin-13 secretion.
|
PAEP,
IL17RB
|
GO:2000669
|
BP
|
negative regulation of dendritic cell apoptotic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell apoptotic process.
|
GAS6,
LILRB1
|
GO:2000670
|
BP
|
positive regulation of dendritic cell apoptotic process
|
Any process that activates or increases the frequency, rate or extent of dendritic cell apoptotic process.
|
LYN
|
GO:2000672
|
BP
|
negative regulation of motor neuron apoptotic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron apoptotic process.
|
ZPR1
|
GO:2000675
|
BP
|
negative regulation of type B pancreatic cell apoptotic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of type B pancreatic cell apoptotic process.
|
CAST,
SRSF6,
TCF7L2
|
GO:2000676
|
BP
|
positive regulation of type B pancreatic cell apoptotic process
|
Any process that activates or increases the frequency, rate or extent of type B pancreatic cell apoptotic process.
|
EIF2S1,
IL6,
HDAC1,
CAPN10
|
GO:2000678
|
BP
|
negative regulation of transcription regulatory region DNA binding
|
Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding.
|
SRI,
LHX2,
PPARA,
ZNF675,
HEY1
|
GO:2000679
|
BP
|
positive regulation of transcription regulatory region DNA binding
|
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
KLF4,
TGFB1,
IGF1,
RB1,
PARP1,
HMGA2,
TWIST1,
TRIM6
|
GO:2000681
|
BP
|
negative regulation of rubidium ion transport
|
Any process that stops, prevents or reduces the frequency, rate or extent of rubidium ion transport.
|
CAB39
|
GO:2000682
|
BP
|
positive regulation of rubidium ion transport
|
Any process that activates or increases the frequency, rate or extent of rubidium ion transport.
|
WNK3
|
GO:2000685
|
BP
|
positive regulation of cellular response to X-ray
|
Any process that activates or increases the frequency, rate or extent of cellular response to X-ray.
|
HMGA2
|
GO:2000687
|
BP
|
negative regulation of rubidium ion transmembrane transporter activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of rubidium ion transmembrane transporter activity.
|
CAB39
|
GO:2000688
|
BP
|
positive regulation of rubidium ion transmembrane transporter activity
|
Any process that activates or increases the frequency, rate or extent of rubidium ion transmembrane transporter activity.
|
WNK3
|
GO:2000691
|
BP
|
negative regulation of cardiac muscle cell myoblast differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell myoblast differentiation.
|
PRICKLE1
|
GO:2000696
|
BP
|
regulation of epithelial cell differentiation involved in kidney development
|
Any process that modulates the frequency, rate or extent of epithelial cell differentiation involved in kidney development.
|
PRKX
|
GO:2000707
|
BP
|
positive regulation of dense core granule biogenesis
|
Any process that activates or increases the frequency, rate or extent of dense core granule biogenesis.
|
PRKCA
|
GO:2000724
|
BP
|
positive regulation of cardiac vascular smooth muscle cell differentiation
|
Any process that activates or increases the frequency, rate or extent of cardiac vascular smooth muscle cell differentiation.
|
GPER1
|
GO:2000726
|
BP
|
negative regulation of cardiac muscle cell differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle cell differentiation.
|
DKK1,
BMP2,
SOX6
|
GO:2000727
|
BP
|
positive regulation of cardiac muscle cell differentiation
|
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
|
GREM1,
TGFB1,
EFNB2,
NRG1,
MEF2C
|
GO:2000736
|
BP
|
regulation of stem cell differentiation
|
Any process that modulates the frequency, rate or extent of stem cell differentiation.
|
TEAD2
|
GO:2000737
|
BP
|
negative regulation of stem cell differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of stem cell differentiation.
|
STAT3,
NOTCH1,
YAP1,
ZFP36L2,
JAG1,
HES1,
TRIM6
|
GO:2000738
|
BP
|
positive regulation of stem cell differentiation
|
Any process that activates or increases the frequency, rate or extent of stem cell differentiation.
|
GSK3B,
PWP1
|
GO:2000739
|
BP
|
regulation of mesenchymal stem cell differentiation
|
Any process that modulates the frequency, rate or extent of mesenchymal stem cell differentiation.
|
PDGFRA
|
GO:2000741
|
BP
|
positive regulation of mesenchymal stem cell differentiation
|
Any process that activates or increases the frequency, rate or extent of mesenchymal stem cell differentiation.
|
SOX6,
SOX9,
LTBP3
|
GO:2000744
|
BP
|
positive regulation of anterior head development
|
Any process that activates or increases the frequency, rate or extent of anterior head development.
|
SSBP3
|
GO:2000751
|
BP
|
histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore
|
Any histone H3-T3 phosphorylation that is involved in chromosome passenger complex localization to kinetochore.
|
GSG2
|
GO:2000753
|
BP
|
positive regulation of glucosylceramide catabolic process
|
Any process that activates or increases the frequency, rate or extent of glucosylceramide catabolic process.
|
PRKCD
|
GO:2000755
|
BP
|
positive regulation of sphingomyelin catabolic process
|
Any process that activates or increases the frequency, rate or extent of sphingomyelin catabolic process.
|
PRKCD
|
GO:2000757
|
BP
|
negative regulation of peptidyl-lysine acetylation
|
Any process that stops, prevents or reduces the frequency, rate or extent of peptidyl-lysine acetylation.
|
HDAC1,
HDAC2,
KLF15
|
GO:2000761
|
BP
|
positive regulation of N-terminal peptidyl-lysine acetylation
|
Any process that activates or increases the frequency, rate or extent of N-terminal peptidyl-lysine acetylation.
|
SOX4
|
GO:2000766
|
BP
|
negative regulation of cytoplasmic translation
|
Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic translation.
|
FMR1,
CPEB4,
CPEB2,
CPEB3,
UNK
|
GO:2000767
|
BP
|
positive regulation of cytoplasmic translation
|
Any process that activates or increases the frequency, rate or extent of cytoplasmic translation.
|
EEF2
|
GO:2000768
|
BP
|
positive regulation of nephron tubule epithelial cell differentiation
|
Any process that activates or increases the frequency, rate or extent of nephron tubule epithelial cell differentiation.
|
CD24
|
GO:2000772
|
BP
|
regulation of cellular senescence
|
Any process that modulates the frequency, rate or extent of cellular senescence.
|
ARNTL,
NUAK1,
RSL1D1,
BMPR1A,
NEK4,
PNPT1,
NEK6,
ZNF277
|
GO:2000773
|
BP
|
negative regulation of cellular senescence
|
Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence.
|
BCL6,
PRKDC,
CDK6,
TWIST1,
BCL2L12
|
GO:2000774
|
BP
|
positive regulation of cellular senescence
|
Any process that activates or increases the frequency, rate or extent of cellular senescence.
|
EEF1E1,
KRAS,
HMGA1,
HMGA2,
YPEL3,
PAWR
|
GO:2000775
|
BP
|
histone H3-S10 phosphorylation involved in chromosome condensation
|
Any histone H3-S10 phosphorylation that is involved in chromosome condensation.
|
CCNB1
|
GO:2000777
|
BP
|
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia
|
Any positive regulation of proteasomal ubiquitin-dependent protein catabolic process that is involved in a cellular response to hypoxia.
|
SIRT2
|
GO:2000778
|
BP
|
positive regulation of interleukin-6 secretion
|
Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
|
IL1B,
HMGB1,
PAEP,
HSPD1,
XBP1,
F2R,
F2RL1,
HYAL2,
TWIST1,
TRPV4,
IL1RAP,
PYCARD
|
GO:2000779
|
BP
|
regulation of double-strand break repair
|
Any process that modulates the frequency, rate or extent of double-strand break repair.
|
DEK
|
GO:2000780
|
BP
|
negative regulation of double-strand break repair
|
Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair.
|
UBR5,
TWIST1,
RNF169,
OTUB1
|
GO:2000781
|
BP
|
positive regulation of double-strand break repair
|
Any process that activates or increases the frequency, rate or extent of double-strand break repair.
|
FOXM1,
SPIDR,
SLF2,
NUDT16,
SLF1
|
GO:2000785
|
BP
|
regulation of autophagosome assembly
|
Any process that modulates the frequency, rate or extent of autophagosome assembly.
|
TBC1D12,
RAB5A,
RAB7A,
NPRL3,
RAB33A,
RAB1B,
TBC1D14,
PIKFYVE
|
GO:2000786
|
BP
|
positive regulation of autophagosome assembly
|
Any process that activates or increases the frequency, rate or extent of autophagic vacuole assembly.
|
RALB,
PIP4K2B,
RAB3GAP1,
KIAA1324,
RAB3GAP2,
SH3GLB1
|
GO:2000791
|
BP
|
negative regulation of mesenchymal cell proliferation involved in lung development
|
Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell proliferation involved in lung development.
|
NFIB
|
GO:2000793
|
BP
|
cell proliferation involved in heart valve development
|
Any cell proliferation that is involved in heart valve development.
|
TWIST1
|
GO:2000794
|
BP
|
regulation of epithelial cell proliferation involved in lung morphogenesis
|
Any process that modulates the frequency, rate or extent of epithelial cell proliferation involved in lung morphogenesis.
|
SOX9
|
GO:2000795
|
BP
|
negative regulation of epithelial cell proliferation involved in lung morphogenesis
|
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell proliferation involved in lung morphogenesis.
|
NFIB
|
GO:2000802
|
BP
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
Any process that activates or increases the frequency, rate or extent of endocardial cushion to mesenchymal transition involved in heart valve formation.
|
TWIST1
|
GO:2000806
|
BP
|
positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled
|
Any process that activates or increases the frequency, rate or extent of termination of RNA polymerase II transcription, poly(A)-coupled.
|
SETX
|
GO:2000807
|
BP
|
regulation of synaptic vesicle clustering
|
Any process that modulates the frequency, rate or extent of synaptic vesicle clustering.
|
PCDH17
|
GO:2000808
|
BP
|
negative regulation of synaptic vesicle clustering
|
Any process that stops, prevents or reduces the frequency, rate or extent of synaptic vesicle clustering.
|
PTEN
|
GO:2000809
|
BP
|
positive regulation of synaptic vesicle clustering
|
Any process that activates or increases the frequency, rate or extent of synaptic vesicle clustering.
|
CDH2,
MAGI2,
NLGN1
|
GO:2000810
|
BP
|
regulation of bicellular tight junction assembly
|
Any process that modulates the frequency, rate or extent of tight junction assembly.
|
MYO1C,
SNAI2,
GJA1,
PRKACA,
PKP2
|
GO:2000811
|
BP
|
negative regulation of anoikis
|
Any process that stops, prevents or reduces the frequency, rate or extent of anoikis.
|
SNAI2,
ITGB1,
ITGA5,
BCL2,
PIK3CA,
NOTCH1,
CAV1,
TLE1,
PTK2,
MCL1,
NTRK2,
PDK4
|
GO:2000812
|
BP
|
regulation of barbed-end actin filament capping
|
Any process that modulates the frequency, rate or extent of barbed-end actin filament capping.
|
MTPN
|
GO:2000813
|
BP
|
negative regulation of barbed-end actin filament capping
|
Any process that stops, prevents or reduces the frequency, rate or extent of barbed-end actin filament capping.
|
LRRC16A
|
GO:2000818
|
BP
|
negative regulation of myoblast proliferation
|
Any process that stops, prevents or reduces the frequency, rate or extent of myoblast proliferation.
|
MSTN
|
GO:2000819
|
BP
|
regulation of nucleotide-excision repair
|
Any process that modulates the frequency, rate or extent of nucleotide-excision repair.
|
CUL4A
|
GO:2000820
|
BP
|
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation
|
Any negative regulation of transcription from RNA polymerase II promoter that is involved in smooth muscle cell differentiation.
|
HEY1
|
GO:2000821
|
BP
|
regulation of grooming behavior
|
Any process that modulates the frequency, rate or extent of grooming behavior.
|
MC4R,
DLG4,
NRXN1
|
GO:2000824
|
BP
|
negative regulation of androgen receptor activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of androgen receptor activity.
|
HEYL
|
GO:2000825
|
BP
|
positive regulation of androgen receptor activity
|
Any process that activates or increases the frequency, rate or extent of androgen receptor activity.
|
BUD31
|
GO:2000827
|
BP
|
mitochondrial RNA surveillance
|
The set of processes involved in identifying and degrading defective or aberrant RNAs that takes place in the mitochondrion.
|
SUPV3L1
|
GO:2000828
|
BP
|
regulation of parathyroid hormone secretion
|
Any process that modulates the frequency, rate or extent of parathyroid hormone secretion.
|
GNAS,
GNAS
|
GO:2000830
|
BP
|
positive regulation of parathyroid hormone secretion
|
Any process that activates or increases the frequency, rate or extent of parathyroid hormone secretion.
|
FGFR1
|
GO:2000845
|
BP
|
positive regulation of testosterone secretion
|
Any process that activates or increases the frequency, rate or extent of testosterone secretion.
|
TMF1
|
GO:2000850
|
BP
|
negative regulation of glucocorticoid secretion
|
Any process that stops, prevents or reduces the frequency, rate or extent of glucocorticoid secretion.
|
CRY1
|
GO:2000852
|
BP
|
regulation of corticosterone secretion
|
Any process that modulates the frequency, rate or extent of corticosterone secretion.
|
POMC
|
GO:2000860
|
BP
|
positive regulation of aldosterone secretion
|
Any process that activates or increases the frequency, rate or extent of aldosterone secretion.
|
BMP6,
C1QTNF1
|
GO:2000864
|
BP
|
regulation of estradiol secretion
|
Any process that modulates the frequency, rate or extent of estradiol secretion.
|
KDM5B
|
GO:2000870
|
BP
|
regulation of progesterone secretion
|
Any process that modulates the frequency, rate or extent of progesterone secretion.
|
GDF9
|
GO:2000872
|
BP
|
positive regulation of progesterone secretion
|
Any process that activates or increases the frequency, rate or extent of progesterone secretion.
|
RETN
|
GO:2000969
|
BP
|
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity
|
Any process that activates or increases the frequency, rate or extent of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity.
|
ARC
|
GO:2000973
|
BP
|
regulation of pro-B cell differentiation
|
Any process that modulates the frequency, rate or extent of pro-B cell differentiation.
|
SOS1,
FLCN,
FNIP1
|
GO:2000974
|
BP
|
negative regulation of pro-B cell differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of pro-B cell differentiation.
|
NOTCH1,
HES1
|
GO:2000978
|
BP
|
negative regulation of forebrain neuron differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of forebrain neuron differentiation.
|
HES1
|
GO:2000979
|
BP
|
positive regulation of forebrain neuron differentiation
|
Any process that activates or increases the frequency, rate or extent of forebrain neuron differentiation.
|
PROX1
|
GO:2000984
|
BP
|
negative regulation of ATP citrate synthase activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of ATP citrate synthase activity.
|
CHCHD10,
PHPT1
|
GO:2000987
|
BP
|
positive regulation of behavioral fear response
|
Any process that activates or increases the frequency, rate or extent of behavioral fear response.
|
PENK,
GJA1,
MEF2C
|
GO:2001013
|
BP
|
epithelial cell proliferation involved in renal tubule morphogenesis
|
Any epithelial cell proliferation that is involved in renal tubule morphogenesis.
|
MTSS1,
LGR5,
MEF2C,
LGR4
|
GO:2001014
|
BP
|
regulation of skeletal muscle cell differentiation
|
Any process that modulates the frequency, rate or extent of skeletal muscle cell differentiation.
|
DDX5,
NR1D2,
DDX17,
UQCC2
|
GO:2001015
|
BP
|
negative regulation of skeletal muscle cell differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of skeletal muscle cell differentiation.
|
S100B,
CAPN3
|
GO:2001016
|
BP
|
positive regulation of skeletal muscle cell differentiation
|
Any process that activates or increases the frequency, rate or extent of skeletal muscle cell differentiation.
|
ARNTL,
GPC1,
MEF2C
|
GO:2001020
|
BP
|
regulation of response to DNA damage stimulus
|
Any process that modulates the frequency, rate or extent of response to DNA damage stimulus.
|
IER3,
NEK4,
CASP9,
MCL1,
NPAS2
|
GO:2001022
|
BP
|
positive regulation of response to DNA damage stimulus
|
Any process that activates or increases the frequency, rate or extent of response to DNA damage stimulus.
|
MYC,
HMGA2,
PRKCD,
FMR1,
NSMCE4A,
BCLAF1
|
GO:2001023
|
BP
|
regulation of response to drug
|
Any process that modulates the frequency, rate or extent of response to drug.
|
ADIRF
|
GO:2001027
|
BP
|
negative regulation of endothelial cell chemotaxis
|
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell chemotaxis.
|
THBS1,
NOTCH1
|
GO:2001028
|
BP
|
positive regulation of endothelial cell chemotaxis
|
Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
|
HSPB1,
MET,
SEMA5A,
PRKD1,
PRKD2
|
GO:2001032
|
BP
|
regulation of double-strand break repair via nonhomologous end joining
|
Any process that modulates the frequency, rate or extent of double-strand break repair via nonhomologous end joining.
|
WHSC1,
DEK
|